Apex Healthcare Bhd operates within the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Apex Healthcare Bhd with three other
drug stores in Asia:
Shanghai No.1 Pharmacy Co Ltd
sales of 1.18 billion Chinese Renmimbi [US$167.55 million]
of which 58%
was Pharmaceutical Retail),
Great Tree Pharmacy Co Ltd
(4.90 billion Taiwanese Dollars [US$160.60 million]
of which 100%
was Drugs,cosmetics and healthcare), and
Sapporo Clinical Laboratory Inc.
based in Japan
(17.46 billion Japanese Yen [US$160.46 million]
During the year ended December of 2018, sales at
Apex Healthcare Bhd were 652.66 million Malaysian Ringgits (US$157.11 million).
increase of 5.2%
versus 2017, when the company's sales were 620.26 million Malaysian Ringgits.
This was the fifth consecutive year of sales increases at Apex Healthcare Bhd
(and since 2013, sales have increased a total of 56%).
Sales of Manufacturing and Marketing saw an increase
that was more than double the company's growth rate: sales were up
73.9% in 2018, from
30.50 million Malaysian Ringgits to 53.03 million Malaysian Ringgits.
Not all segments of Apex Healthcare Bhd experienced an increase in sales in 2018:
sales of Corporate fell 4.5% to 9.10 million Malaysian Ringgits.
(However, this segment's sales were only a very small portion of the company's overall sales).